Concord Biotech (CONCORDBIO.BO) Earnings Analysis
Concord Biotech (CONCORDBIO.BO) next reports earnings on 2026-08-07, consensus EPS 7.33 INR. Last quarter (2026-05-29) it missed with EPS 8.5 INR vs 8.9 INR est (-4.5%). It has beaten estimates in 1/6 recent quarters (17%). Trailing P/E 51.17.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CONCORDBIO.BO next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | 7.33 INR |
| Revenue estimate | 2.72B |
CONCORDBIO.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-29 | 8.5 INR | 8.9 INR | -4.5% | Miss |
| 2026-02-11 | 6.3 INR | 7.2 INR | -12.5% | Miss |
| 2025-09-30 | 6.03 INR | 5.3 INR | +13.8% | Beat |
| 2025-06-30 | 4.21 INR | 6.15 INR | -31.5% | Miss |
| 2025-02-13 | 7.3 INR | 8.9 INR | -18% | Miss |
| 2024-11-11 | 9.15 INR | n/a | n/a | n/a |
| 2024-08-09 | 5.7 INR | 6.5 INR | -12.3% | Miss |
Beat rate: 1/6 (17%) over reported quarters with consensus data.
CONCORDBIO.BO valuation and analyst view
| Trailing P/E | 51.17 |
|---|---|
| Trailing EPS | 24.81 INR |
| Price / book | 6.62 |
| Dividend yield | 0.84% |
| Market cap | 134.79B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Concord Biotech (CONCORDBIO.BO)'s next earnings date?
Concord Biotech is next scheduled to report on 2026-08-07, with a consensus EPS estimate of 7.33 INR and revenue estimate of 2.72B.
Did CONCORDBIO.BO beat earnings last quarter?
In its 2026-05-29 report, CONCORDBIO.BO posted EPS of 8.5 INR versus a 8.9 INR estimate — a miss of 4.5%.
What is CONCORDBIO.BO's earnings track record?
Over the last 6 reported quarters with consensus data, CONCORDBIO.BO beat estimates 1 times (17%).
What is CONCORDBIO.BO's current P/E ratio and EPS?
CONCORDBIO.BO trades at a trailing P/E of 51.17 on trailing EPS of 24.809924442369443 INR.
What do analysts rate CONCORDBIO.BO?
CONCORDBIO.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.